BETA Technologies launches IPO of 25 million shares priced $27-$33
Investing.com - Mizuho has reduced its price target on Align Technology (NASDAQ:ALGN) to $170.00 from $210.00 while maintaining an Outperform rating on the stock. The dental technology company, currently trading at $125.79 and near its 52-week low of $122, maintains a GOOD financial health score according to InvestingPro analysis.
The firm expects Align to report third-quarter 2025 revenues of $985 million, representing a 1% year-over-year increase, slightly above the Street’s estimate of $976 million and within the company’s guidance range of $965-985 million.
Mizuho projects earnings per share of $2.45 for the third quarter, compared to analysts’ consensus of $2.41, but expressed concerns about the visibility of sequential improvement expected in the fourth quarter of 2025.
The price target reduction reflects Mizuho’s application of a lower price-to-earnings multiple of 16x (down from 20x) on its unchanged 2026 EPS estimate of $10.60, citing recent data points showing minimal industry improvement.
The American Dental Association’s third-quarter 2025 industry survey and the University of Michigan consumer sentiment index, which remained near lows at 55.0 in September, suggest a "lower likelihood of upside operational performance" in the second half of 2025 and into 2026, according to the firm.
In other recent news, Align Technology has been in the spotlight for several notable developments. Jefferies downgraded Align Technology from Buy to Hold, citing concerns over market penetration and ongoing share loss in the clear aligner market. The downgrade came after Jefferies’ survey of U.S. orthodontists and dentists showed expectations for only modest market penetration through 2030. Meanwhile, Align Technology filed a complaint with the U.S. International Trade Commission against Angelalign Technology, alleging patent infringement related to clear aligners. Piper Sandler maintained an Overweight rating on Align Technology, noting the company’s ongoing patent litigation efforts across multiple regions, including the United States, Europe, and China. Stifel also reiterated its Buy rating, highlighting Align’s new pricing strategies aimed at increasing market share among teenagers and reducing provider defections. Additionally, Align Technology announced the termination of Stuart Hockridge, Executive Vice President of Global Human Resources, effective May 2026, with severance terms aligned with his employment agreement. These recent developments are shaping the current landscape for Align Technology and its stakeholders.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.